Blindsight的工作原理是与大脑的视觉皮层协同，刺激神经元以形成视觉图像。尽管在初始阶段，这款植入物只能提供相当于老游戏机8Bit图形的低分辨率视力，但马斯克表示，未来这项技术有望扩展人类的感知边界，甚至可能让用户具备看到红外线和紫外线的能力。

据马斯克所说，首次人体测试可能最早在 2025 年底开始。此前，Neuralink 已为其植入物注册了三个新名称：Telepathy、Blindsight、Telekinesis。 其中，第一个 Telepathy 已经进行测试，并帮助瘫痪用户通过思想与电脑交互。Blindsight 旨在与大脑的视觉皮层协同工作，刺激神经元形成视觉图像。

测试进展与成果 据马斯克所说，Blindsight已经在猴子身上进行了测试，并且已经稳定运行了数年。初步结果显示，这种植入物能够有效刺激大脑视觉皮层，产生低分辨率的视觉图像。首次人体测试可能最早在2025年底开始，这标志着这项技术迈向实际应用的重要一步。

Elon Musk has said that the first person to receive the Blindsight version of Neuralink will be treated this year.

Elon Musk's brain-chip company Neuralink is set to implant its revolutionary Blindsight chip on its first human patient in 2025. The test chip, approved by the ...

首次人体测试可能最早在 2025 年底开始。此前，Neuralink 已为其植入物注册了三个新名称：Telepathy、Blindsight、Telekinesis。

Neuralink’s Blindsight implant aims to restore vision for the blind using a brain-computer interface, with future potential for superhuman sight beyond human capabilities.

Neuralink's Blindsight chip, set for human trials in 2025, aims to restore vision for the blind by directly stimulating the brain's visual cortex.

Elon Musks Neuralink is set to revolutionize vision restoration with its groundbreaking Blindsight technology, aimed at giving sight back to the blind. With human trials starting by 2025, this ...

Elon Musk’s brain chip company, Neuralink, is aiming to achieve a major medical milestone by the end of 2025 with the first human implantation of its artificial visual prosthesis, Blindsight.

The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.